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                      Periodontitis is a chronic infectious disease of the supporting tissues of 
the teeth affecting approximately 10% of the population which may lead to loss of 
teeth1.The pocket formation and ulceration of the epithelial lining which is formed 
during inflammation of periodontal tissues form ports of entry which may lead to 
transient bacteremia2, 3. Periodontal disease is a low grade systemic inflammation 
leading to increase in number of platelet activation, 4 and platelet numbers decrease 
after periodontal therapy5. Interestingly Porphyromonas gingivalis and Streptococcus 
sanguis induce platelet activation and aggregation in vitro and in animal studies6. 
   The ultimate goal of periodontal treatment is halting periodontal 
disease progression and regeneration of tissues which was destroyed as a result of 
periodontal disease. Attaining a complete periodontal regeneration with this current 
regenerative procedures offer a limited success.4Various biomaterials based on 
endogenous regenerative technology (ERT) have been used for periodontal tissue 
regeneration in addition to autogenous5 and allogenic bone grafts. Platelets have 
important role in hemostasis and wound healing along with various growth factors. 
Hence lead to the evolution of platelet concentrates into existence for periodontal 
regeneration. Initially fibrin glue was originally described in 19707 and these platelet 
rich plasma by Marx et al 1998, contains fibrin, fibronectin and vitronectin which 
leads a cell to osteoconduction& epithelial migration, but it is least favorable to 
cytokine and cellular migration. 
                        Thus second generation platelet concentrates Platelet Rich Fibrin was 
developed by Choukroun et al 2001, It is a polymerized fibrin matrix in a tetra 
molecular structure with >97% of the platelets, cytokines, leuckocytes & circulating 
stem cells.13 It is based on simple strategy of enhancing healing capacity of natural 
blood clot by supplementing the natural blood clot with growth factors. The third 
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generation of platelet concentrate Titanium PRF was introduced by Tunali et al 2013 
by using biocompatible material titanium. In titanium prepared PRF, fibrin network 
pattern are well organized and appeared thicker compared to PRF. 
                          Various factors that influence the fibrin network pattern of PRF & T- 
PRF are genetic factors, acquired factors like variations in XIII & thrombin in plasma 
hyperchromocystemia, blood flow, platelet activation, hypertension, strain 
hyperglycemia, medication, oxidation, and cigarette smoking9.Thus the fibrin network 
pattern of this platelet concentrate can be changed due to periodontal disease. The aim 
of present study is to evaluate the various fibrin network patterns of PRF & T-PRF in 
patients with & without periodontitis. 
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AIM 
 To compare fibrin network pattern changes of platelet rich fibrin and titanium 
prepared platelet rich fibrin in healthy, gingivitis, generalized chronic 
periodontitis and generalized aggressive periodontitis patients. 
OBJECTIVES 
 Preparation of platelet rich fibrin and titanium prepared platelet rich fibrin by 
centrifugation. 
 To compare the variation in the fibrin network pattern of platelet rich fibrin 
and titanium prepared platelet rich fibrin clot by histological analysis. 
 To compare the variation in the fibrin network pattern of healthy, gingivitis 
and generalized chronic periodontitis and generalized aggressive periodontitis 
patients. 
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Tomoyuki Kawase et al (2003)10 investigated PRP’s action on extracellular matrix 
production in periodontal ligament (PDL) and osteoblastic MG63 cell cultures and 
found Gel-like material rapidly (<30 minutes) formed in cultures of either PDL or 
osteoblastic MG63 cell cultures after addition of PRP (≥0.5%). PRP changed cell 
shape and up-regulated type I collagen at 24 hours. Fibrinogen was detected in the 
PRP preparations and insoluble fibrin networks were found in the newly formed gel-
like material. PRP’s action on collagen synthesis was mimicked by purified 
fibrinogen and blocked by thrombin inhibitor. Thrombin was expressed both in PDL 
and MG63 cells and concluded these findings demonstrated that the gel-like material 
formed in cell cultures of either PDL or MG63 cells is fibrin clot that helps in 
collagen synthesis in the extracellular matrix and promote wound healing. 
David M. Dohan et al (2006)11 evaluated the biochemical properties of generations of 
surgical additives, fibrin glues, (cPRP) and PRF. The 3-dimensional fibrin 
architecture is dependent on artificial clinical polymerization processes, such as 
massive bovine thrombin addition. The fibrin network of PRF preparation was similar 
to the natural one which leads to organized cell migration and proliferation. 
David M. Dohan et al (2006)12 investigated the PRF, platelets activation and their 
cytokine release. He quantified TGFb-1, PDGF-BB and IGF-I within PPP (platelet-
poor plasma) and PRF clot exudate serum. The incorporation of platelet cytokines and 
glycanic chains in the fibrin meshes were found during PRF processing. Theses 
cytokine release during PRF preparation will explain the healing properties of PRF. 
David M. Dohan et al (2006)13 investigated the immune features of PRF and 
quantified proinflammatory cytokines (IL-1b, IL-6, and TNF-a), (IL-4) an anti-
inflammatory cytokine, and (VEGF). This explains the immune regulating properties 
of PRF which helps in reducing postoperative infections. 
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Joseph Choukroun, et al (2006)14 investigated biology of PRF to determine the 
potential fields of clinical applications. The fundamental events angiogenesis, 
immune control, circulating stem cells trapping, and wound-covering epithelialization 
were concentrated. It plays an important role in neovascularization, wound closing, 
tissue remodelling. This initial research helps in future PRF applications, including 
bone surgery. 
Joseph Choukroun et al (2006)15 nine sinus floor augmentations were performed. In 
6 sites, PRF with FDBA particles, and FDBA without PRF was used in 3 sites.  After 
4 months and 8 months, bone specimens were harvested and treated for histologic 
analysis. It revealed the newly formed bone and connective tissue. The results were 
same for both groups. PRF with FDBA for Sinus floor augmentation leads to a 
reduction of healing time prior to implant placement. This healing time could be 
reduced to 4 months. 
Hyeon-Jung Lee et al (2007)16 evaluated the use of autogenous bone in combination 
with platelet-enriched fibrin for maxillary sinus augmentation with simultaneous 
implant placement 12 sinuses in dogs bilaterally. In the right sinus, autogenous bone 
mixed with platelet-enriched fibrin glue was grafted. In the left sinus, autogenous 
bone alone was grafted in the control group. 2 dental implants were inserted into the 
grafting material.  After 6 months the animals were killed and examined. He 
concluded that it showed enhanced Osseo integration of dental implants and increased 
height of new bone. 
Antoine Diss et al (2008)17 Implants were placed using Platelet rich fibrin in the 
bone-added osteotome sinus floor elevation (BAOSFE) technique. The survival rate at 
abutment tightening (6 to 12 weeks of healing) and at 1 year was calculated. The 
radiographic analysis determined the mean residual bone height (RBH) at implant 
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placement, the change in bone level. He assessed the endosinus bone changes in the 
mesial and distal implant sides at 1 year. The BAOSFE procedure with Platelet rich 
fibrin can lead to an endosinus bone gain. Despite a limited RBH, a healing period of 
2-3 months was found to be sufficient during abutment tightening. At 1 year, 
formation of a new recognizable bone structure delimiting the sinus floor was 
identified. 
Chung-Hung Tsai et al (2009)18investigated the biologic effects of PRF on human 
gingival fibroblasts (GFs), periodontal ligament (PDL) cells, oral epithelial cells, and 
osteoblasts in 10 healthy volunteers. Blood collected and centrifuged at 3000 rpm for 
12 minutes with a PC-02 table Centrifuge. The U2OS osteoblast cell line was 
examined by trypan blue and tetrazolium bromide reduction assays to view the cell 
viability and proliferation. PRF did not interfere with cell viability,but stimulated cell 
proliferation of osteoblasts (135% of the control), PDL cells (130% of the control), 
and GFs (120% of the control) during a 3-day culture period. It suppressed oral 
epithelial cell growth to as low as 80% of the control. In phase-contrast microscopy, 
GFs, PDL cells, and osteoblasts were attached at the margins of PRF. He suggested 
that PRF modulates cell proliferation in a cell type specific manner and its actions 
may be beneficial for periodontal regeneration. 
David M. Dohan Ehrenfest et al (2010)19 examined the processed PRF by light 
microscopy and scanning electron microscopy. Depending on the centrifugation 
forces approximately platelets 97% and leukocytes>50%  were concentrated and 
showed a specific three-dimensional distribution, beyond the red blood cell base, in 
first few millimeters, Platelets and fibrin formed large clusters of coagulation. The 
fibrin network was very mature and dense. Moreover, the PRF architecture between 
groups using the different tested collection tubes and compression techniques no 
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difference was found, even if these two parameters could have influenced the growth 
factor content and biologic matrix properties. 
Lekovic V et al (2011)20 used 17 paired intrabony defects were treated either with 
PRF or with PRF–Bovine porous bone mineral (BPBM) combination. Changes in 
defect fill, pocket depth, attachment level and were examined. The results showed that 
PRF can improve clinical parameters associated with human intrabony periodontal 
defects, and BPBM reinforces effect of PRF in periodontal regeneration. 
Anuj Sharma et al (2011)21 used 36 mandibular grade II furcation defects were 
randomly treated either with autologous PRF and OFD or OFD. Sulcus bleeding 
index, relative vertical and horizontal clinical attachment level Plaque index, probing 
depth, gingival marginal level, and radiographic bone defect were recorded at baseline 
and after 9 months. All clinical and radiographic parameters showed statistically 
significant improvement at the treated sites. 
Thorat MK et al (2011)22 examined thirty-two intra-bony defects (one site/patient) 
and treated either with PRF or a conventional open flap debridement alone. Clinical 
parameters and radiographic features were recorded at baseline and after 9 months. In 
both the groups, intra-bony defect fill was calculated on standardized radiographs by 
software. Clinical parameters were improved and greater intra-bony defect fill at sites 
treated with PRF group. 
Kai-Chiang Yang et al (2011)23 in a miniatures wine unerupted second molar tooth 
buds were obtained and cultured in vitro for 3 weeks to obtain dental bud cells 
(DBCs). Platelet rich fibrin and fibrin glues were prepared from blood before surgery. 
The original alveolar sockets were filled with the DBC-fibrin glue-PRF composite. 
After 36 weeks of implantation, radiographic and histological examinations and 
Immunohistochemical staining were used to examine the regenerated tooth structure 
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and to detect tooth regeneration specific proteins. Complete crown, root, pulp, 
enamel, dentin, odontoblast, cementum, blood vessels, and periodontal ligaments in 
indiscriminate shape were developed in one pig. Dentin matrix protein, Cytokeratin 
14, vascular endothelial growth factor, and osteopontin were found in another animal 
with an unerupted tooth. This study showed a complete tooth regenerated by DBCs 
seeded into fibrin glue-PRF. 
Y-C Chang et al (2011)24 evaluated the effects of PRF on PDLFs were determined by 
measuring the expression of osteoprotegerin (OPG),phosphorylated extracellular 
signal-regulated protein kinase (p-ERK), and alkaline phosphatase (ALP) activity. He 
studied the feasibility and safety of regeneration of infrabony defects. PRF increased 
p-ERK, OPG and ALP expression which helps in periodontal regeneration. 
Sashwati Roy et al (2011)25 showed the kinetics of the viability of platelet-embedded 
fibrin matrix. PRFM released growth factors was observed. The endothelial mitogenic 
response via extracellular signal-regulated protein kinase activation pathway by 
vascular endothelial growth factor released from PRFM. This study showed that 
chronic wounds were with proliferation of endothelial cells and enhanced wound 
angiogenesis. 
Gulnihal Eren et al (2012)26 assigned CAF +PRF (test) or CAF+SCTG (control) sites 
in a 23-year-old female patient with bilateral gingival recessions in maxillary cuspids. 
Clinical parameters and clinical photographs were taken at baseline; 1, 3, and 6 
months; and 1 year. Improved root coverage, gingival thickness, and keratinized 
tissue width were resulted in both sites and remained stable for 1 year. PRF seems to 
be eliminates the requirement of a donor site. 
C-L Wu et al (2012)27 determined the effects on cell attachment, proliferation, 
phosphorylated Akt, heat shock protein 47 (HSP47) and lysyl oxidase (LOX) 
Review of Literature 
9 
 
expression on human osteoblasts measured with WST-1 and alamar blue respectively. 
PRF stimulate U2OS cell attachment compared with untreated controls and increase 
osteoblast proliferation during a 5-day incubation period ,increase Akt 
phosphorylation in a time-dependent manner, Collagen-related proteins HSP47 and 
LOX were significantly elevated by stimulation with PRF compared with untreated 
controls. He suggested that PRF is capable of enhancing osteoblast attachment, 
proliferation and simultaneously upregulating collagen-related protein which 
promoteregeneration of bone. 
A. R Pradeep et al (2012)28 90 intrabony defects were treated either with PRF with 
open flap debridement or autologous PRP with open flap debridement or open flap 
debridement alone. After 9 months probing depth (PD), clinical attachment level 
(CAL), intrabony defect depth and % defect fill were recorded. Both groups showed 
similar results. 
Mustafa Tunali et al (2013)29 90developed a new titanium-prepared, platelet-rich 
fibrin (T-PRF) with the protocol for preparation, which is based on the presumption 
that platelets can be activated by titanium tubes may be more effectual than the glass 
tubes used by Choukroun in his platelet-rich fibrin (PRF) method and within 30 days 
of treatment with T- PRF induced the new bone formation with connective tissue 
which helps in wound healing. 
Bajaj P et al (2013)30  investigated mandibular degree II furcation defects with either 
Platelet Rich Fibrin with open flap debridement (OFD; 24defects) or autologous PRP 
with OFD (25), or OFD alone (23) in seventy-two patients. All clinical and 
radiographic parameters relative vertical clinical attachment level and horizontal 
clinical attachment level, probing depth, along with gingival marginal level showed 
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statistically significant improvement at both the test sites compared to open flap alone 
group. 
Jayant R Ambulgekar et al (2014)31 stated that Aggressive periodontitis causes rapid 
destruction of the periodontal attachment apparatus & the supporting alveolar bone. In 
aggressive periodontitis early diagnosis and treatment is critically important because 
preventing further destruction is often more important than attempting to regenerate 
lost supporting tissues. An organised treatment plan is required. A critical aspect of 
periodontal regeneration is the stimulation of the series of events & cascades at some 
point, which can result in the coordination & completion of integrated tissue 
formation. The growth factors in platelet rich fibrin are involved in wound healing & 
which helped in tissue regeneration. It is both nontoxic & non-immune reactive. 
Ashish Agarwal et al (2015)32 determined the addition of PRF with a DFDBA in the 
treatment of intrabony periodontal defects in sixty patients. After 12 months, resulted 
in significant changes in all clinical and radiographic parameters and concluded that a 
combination of PRF and DFDBA is more effective than DFDBA with saline for the 
treatment of infrabony periodontal defects 
Mustafa Tunali et al (2015)33developed platelet-rich product- titanium prepared 
platelet-rich fibrin (T-PRF). T-PRF is based on the presumption that platelets can be 
activated by titanium more effectively than the silica activators used with glass tubes 
in Chouckroun's platelet-rich fibrin (PRF) and decided that T-PRF membrane can be 
successfully used for augmentation of bone. 
Pradeep et al (2015)34 evaluated the efficacy of PRF, 1% Metformin gel and 
PRF+1%MF gel, with open flap debridement (OFD), in the treatment of intrabony 
defects in chronic periodontitis (CP) patients and found Platelet Rich Fibrin, 
1%MeforminF and Platelet Rich Fibrin+1% Metfromin groups showed significant 
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probing depth reduction and relative attachment loss gain than open flap debridment 
group. In PRF+1% MF group showed probing depth reduction and mean RAL gain as 
compared to PRF alone or MF alone at 9 months. He concluded PRF+1% MF group 
showed greater enhancements in clinical parameters with higher percentage intrabony 
defect depth reduction in CP patients. 
Ana B. Castro et al (2016)35 analyzed the regenerative potential of Leucocyte- and 
Platelet Rich Fibrin (L-PRF) during periodontal surgery. Databases were collected 
from an electronic and hand search and reviewed the randomized clinical trials only. 
Pocket depth (PD), clinical attachment level (CAL), bone fill, and keratinized tissue 
width (KTW), recession reduction, and root coverage (%) were considered as 
outcome. When possible, meta-analysis was performed. Twenty-four articles fulfilled 
the inclusion and exclusion criteria. Meta-analysis was performed in these three 
subgroups intrabony defects (IBDs), furcation defects, and periodontal plastic 
surgery. Significant PD reduction (1.1±0.5mm, p<0.001), CAL gain (1.2±0.6mm, 
p<0.001), and bone fill (1.7±0.7mm, p<0.001) were found when comparing L-PRF to 
open flap debridement (OFD) in IBDs. For furcation defects, significant PD reduction 
(1.9±1.5mm, p=0.01), CAL gain (1.3±0.4mm, p<0.001), and bone fill (1.5±0.3mm, 
p<0.001) were reported when comparing L-PRF to OFD. When L-PRF was compared 
to a connective tissue graft, were recorded for PD reduction (0.2±0.3mm, p>0.05), 
CAL gain (0.2±0.5mm, p>0.05), KTW (0.3±0.4mm, p>0.05), and recession reduction 
(0.2±0.3mm, p>0.05). PRF enhances periodontal wound healing.  
Jane K. Chadwick et al (2016)36Thirty-six patients completed the study protocol. 
Each patient contributed a single intrabony defect, which was randomized to receive 
either DFDBA or PRF. Clinical and standardized radiographic data were collected at 
baseline and 6 months after treatment. Primary outcomes measures included (1) 
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radiographic bone fill as measured from the CEJ to base of bony defect, and (2) 
change in clinical attachment level (CAL). Both treatment groups had significant 
gains in CAL as well as bone fill, with no significant differences in outcomes between 
groups. Treatment of intrabony defects with either DFDBA or PRF resulted in a 
significant gain in CAL as well as bone fill after 6 months of healing, with no 
significant difference between materials. 
 
Santosh S. Martande et al (2016)37 used PRF with Atrovastatin in bone defects of 
ninety six individuals and they were grouped as OFD with PRF, OFD with PRF+1.2% 
Atrovastatin and OFD alone. Clinical parameters probing depth (PD), relative 
attachment level (RAL),site specific plaque index (PI), modified sulcus bleeding 
index (mSBI), and gingival marginal level (GML) were examined at baseline before 
surgery and 9 months post-operatively. Intra-bony defect depth reduction was 
evaluated radio graphically at baseline and 9 months.PRF+1.2% ATV and PRF alone 
showed significantly greater PD reduction and RAL gain as compared to OFD alone 
at 9 months. Platelet Rich Fibrin+1.2% ATV showed same refinement in clinical 
parameters with greater reduction in percentage radiographic defect depth as 
compared to PRF alone in treatment of intrabony defects in CP individuals. Thus 
1.2% Atrovastatin was unsuccessful to augument the regenerative potential of PRF 
alone inintrabony defects. 
A R Pradeep et al (2016)38 investigated total of 90 Intrabony defects and were 
randomly assigned to one of the 3 treatment groups: 1) OFD alone, 2) OFD + PRF 
and 3) OFD + PRF + 1.2% Rosuvastatin (RSV) gel placement.  Periodontal 
parameters: probing depth (PD), clinical attachment (CA) level, Plaque index (PI), 
modified sulcus bleeding index and IBD depth were recorded at baseline and at 9 
months. Significant PI and mSBI reductions were observed in all the 3 groups. PRF 
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placement significantly enhanced the improvements in periodontal parameters than 
OFD alone. 1.2% RSV with PRF results in significantly higher periodontal 
regeneration compared to OFD alone or with PRF. 
Mustafa Tunali et al (2016)39 conducted preliminary study of a new centrifugation 
method, which aimed to change the direction of fibrin formation during the platelet 
aggregation and make T-PRF much denser and more resistant. According to this 
hypothesis, it is possible to use in guided bone, and guided tissue regeneration more 
successfully and concluded that the pilot study defines 10 min MT-PRF as a new 
autogenous product with superior fibrin network and results showed that, fibrin 
formation was made more organised and denser with 2-way direction centrifugation. 
Gulbaharustaoglu et al (2016)40 determined the clinical effects of titanium prepared, 
platelet rich fibrin on human palatal mucosal healing (PMWH) and to identify its 
effect on time –dependent changes in palatal soft tissue thickness(PSTT) in terms of 
histoconduction, free gingival graft donor sites were treated with T-PRF and 
compared with an untreated control group. Colour match, complete epithelisation 
were recorded on days 3, 7, 14, and 21. Pain level and bleeding status were recorded 
for the first 7 days. PSTT was measured at baseline and after 1 and 6 months. 
Humeyra Aydemir Turkal et al (2016)41 treated infrabony (IBD) defects in chronic 
periodontitis with enamel matrix derivative alone and with enamel matrix derivative 
with platelet rich fibrin using split mouth design. Clinical and radiographic 
measurements were recorded at baseline (BL) and at 6 months following therapy. 
Both therapies showed in significant improvement in Intra bony defect treatment. 
Addition of PRF did not improve the clinical and radiographic outcomes. 
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Masako Fujioka-Kobayashi et al (2017)42 studied characterizes how centrifugation 
speed (G-force) along with centrifugation time influence growth factor release from 
fibrin clots, as well as the cellular activity of gingival fibroblasts exposed to each PRF 
matrix and found the low-speed concept (A-PRF, A-PRF+) demonstrated a significant 
increase in growth factor release of transforming growth factor (TGF)-b1, platelet-
derived growth factor (PDGF), epidermal growth factor, and insulin-like growth 
factor, with A-PRF+ being highest of all groups. Although all PRF formulations were 
extremely biocompatible due to their autogenous sources, both A-PRF and A-PRF+ 
demonstrated significantly higher levels of human fibroblast migration and 
proliferation compared with L-PRF. Furthermore, gingival fibroblasts cultured with 
A-PRF+ demonstrated significantly higher messenger RNA (mRNA) levels of PDGF, 
TGF-b, and collagen1 at either 3 or 7 days and concluded the modifications to 
centrifugation speed and time with the low-speed concept favor an increase in growth 
factor release from PRF clots. This, in turn, may directly influence tissue regeneration 
by increasing fibroblast migration, proliferation, and collagen mRNA levels. Future 
animal and clinical studies are now necessary. 
Kazushige Isobe et al (2017)43 studied the mechanical and chemical characterization 
of fibrin clot membranes prepared from advanced platelet-rich fibrin (A-PRF) or 
concentrated growth factors (CGF). They have been used as bioactive barrier 
membranes for regeneration of alveolar bone tissue because of their rapid 
biodegradability which have and found out when A-PRF and CGF are prepared by 
essentially similar mechanisms. Both membranes have identical mechanical and 
chemical properties. It was mechanically weaker and degradable which was prepared 
by a different mechanism. 
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Pavan Bajaj et al (2017)44 explored the efficacy of PRF in treatment of 54intrabony 
defects in 17 patients with aggressive periodontitis and compared with Open Flap 
Debridment technique alone. After 9 months, Clinical and radiological parameters 
such as probing depth, clinical attachment level, intrabony defect depth and % defect 
were significantly greater in PRF as compared to control group. Greater bone fill was 
observed in PRF group than conventional OFD alone. 
David M. Dohan Ehrenfest et al (2017)45 evaluated the mechanical vibrations 
appearing during centrifugation in four models of commercially available table-top 
centrifuges used to produce L-PRF and  studied the influence  of the centrifuge 
characteristics on the cell and fibrin architecture of a L-PRF clot and membrane and 
also evaluated how changing some parameters of the L-PRF protocol may influence 
its biological signature, independently from the characteristics of the centrifuge and 
concluded that the centrifuge characteristics and centrifugation protocols have a very 
significant effect on the cell, growth factors and fibrin architecture of a L-PRF clot 
and membrane and that any modification of the original L-PRF material and method 
shall be clearly investigated and identified separately from the original methods, in 
order to avoid creating confusion and inaccurate results in the literature.Thus 
emphasized that periodontitis can be a contributing factor in the development of 
cardiovascular disease. 
Taner Arabacı et al (2017)46 evaluated benefaction of platelet-rich fibrin (PRF) with 
conventional flap surgery on growth factor levels in gingival crevicular fluid (GCF) 
and periodontal healing and concluded PRF membrane combined with open flap 
debridement OFD provides significantly higher GCF concentrations of angiogenic 
biomarkers for 2 to 4 weeks and better periodontal healing in terms of conventional 
flap sites. 
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J. Du et al (2017)47studied the efficacy and influence of aspirin in local defects and 
the use of platelet-rich fibrin (PRF) in periodontal defects were investigated.  He 
studied delivery system to carry sustained-release aspirin/salicylic acid to improve 
regeneration of alveolar bone and can be used as suitable scaffold a was determined 
and found the PRF/aspirin complex provided a sustained-release aspirin/salicylic acid. 
High concentrations were found at 4 hours after transplantation and were maintained 
to 48 hours at 37°C; the total concentration of aspirin/salicylic acid of 83.5 mg/mL 
was released, respectively. Periodontal ligament mesenchymal cells proliferation and 
migration were enhanced. Micro-computed tomography and histological data showed 
that both groups enhanced formation of bone. Moreover, the new bone formation was 
two times greater in the PRF/aspirin complex group than the PRF group and 
concluded Aspirin/salicylic acid could be sustained-released from PRF/aspirin 
complex, which could increase the role of mesenchymal cells and hamper 
inflammation. This study might provide a new safe and easy clinical treatment 
procedure to improve periodontal bone regeneration. 
Anirban Chatterjee et al (2017)48 compared the variation in fibrin network pattern of 
titanium platelet-rich fibrin and platelet-rich fibrin in smoker participants and 
hypertensive patients through histological analysis. The fibrin clot pattern of PRF and 
TPRF in hypertensive and smoker participant varied as compared to healthy 
participants, but showed a better organization of network and increased entrapment of 
cellular components were seen in TPRF clot. 
Umesh Pratap Verma et al (2017)49 gathered systematic reviews from January 2006 
to August 2016 highlighting PRF for soft and hard tissue regeneration and/or wound 
healing, in various studies like in vitro, animal, and clinical studies utilizing PubMed 
electronic database. He confirmed that PRF is a remedial regenerative biomaterial that 
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has vast clinical applications in general surgeries as well as dental perspectives. The 
use of PRF alone or in combination with other biomaterials (such as bone grafts, soft 
tissue grafts, and pharmacologic agents) given safe and guaranteed results in the 
enhancements of clinical and radiographic parameters in the treatment of periodontal 
osseous defects, PRF also provided an added advantage in enhancing in gingival 
tissue width and thickness (gingival biotype). 
 Eva Dohle et al (2017)50presented autologous PRF-based matrices generated by 
LSCC a very beneficial therapeutic tool by simply profiting from the natural 
conditions in the human body. Using PRF containing blood plasma, platelets and 
leukocytes for tissue engineering purposes results in the initiation of wound healing 
processes in the established co-culture system of primary osteoblasts (pOBs) and 
outgrowth endothelial cells (OECs)in vitro with special attention to the improvement 
of the process of angiogenesis. 
Makoto Horimizu1 et al (2017)51 evaluated the combined use of hCP human – 
cultured alveolar bone derived periosteal sheets with PRF complex could facilitate 
bone regeneration synergistically was evaluated in nude mice. At 4 weeks post 
implantation, new bone formation was evaluated by using μCT. Cell growth and 
neovascularization were evaluated by histochemical and immunohistological 
methods. In the subcutaneous tissue, mineral deposit formation, collagen deposition, 
and number of vessels were higher in the hCP + PRF group than in the hCP alone 
group. At 4 weeks post implantation, new bone formation was evaluated by using 
μCT. Cell growth and neovascularization were evaluated by histochemical and 
immunohistological methods. In the subcutaneous tissue, mineral deposit formation, 
collagen deposition, PCNA-positive cells and number of vessels were higher in the 
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hCP + PRF group than in the hCP alone group. In the calvarial defect models, new 
bone formation was significantly higher in the hCP + PRF group. 
Shantipriya Reddy et al (2018)52 examined the clinical and radiographic outcomes of 
two intrabony defects treated with titanium prepared platelet rich fibrin, after 6 
months followup revealed a notable reduction in Probing Depth (PD) and Relative 
Attachment Level (RAL) gain as well as radiographic intrabony defect depth 
reduction and increase in bone density helping the role of various growth factors 
present in the T-PRF in hasten the soft and hard tissue healing. 
Taner Arabaci et al (2018)53 investigated the periodontal outcomes in chronic 
periodontitis patient treated with titanium-prepared platelet-rich fibrin (T-PRF) 
combined with open flap debridement (OFD) on biological markers in gingival 
crevicular fluid (GCF) and clinical outcomes in twenty-nine participants. At baseline 
and 2, 4, and 6 weeks postoperatively, GCF growth factor levels and relative receptor 
activator nuclear factor kappa-B/osteoprotegerin (RANKL/OPG) ratio were analysed, 
and after 9 months, RAL gain, mean PD reduction, and GML change were notably 
higher in the OFD+T-PRF sites. After 2 weeks, both groups showed increased growth 
factor levels, followed by reductions at weeks 4 and 6. After 6 week post-surgery, 
GCF growth factor levels in the test group were seen at higher concentrations with 
respect to control group. Relative RANKL/OPG ratio was found significantly 
decreased in the OFD+T-PRF group compared to the OFD group at 6-week period. 
Anil Kumar et al (2018)54 explored the effect of PRF/BCP on differentiation and 
survival of osteoclasts obtained from peripheral blood of Chronic Periodontitis 
patients and compared with healthy patients. He assessed the number of osteoclasts by 
Tartrate acid resistant acid phosphatase (TRAP)-positivity. The mechanism of 
apoptosis was studied with reference to expression of Bcl-2, Bax, Bcl-xL, Nuclear 
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Factor Kappa-light chain enhancer of activated B cells (NF-κB), caspase 3/9 and 
Deoxyribonucleic acid (DNA) fragmentation. The results showed PRF/BCP displayed 
an inhibitory role in osteoclasts formation and its molecular mechanism of action was 
related to the apoptosis induction through intrinsic mitochondrial pathway. 
Ishita Wanikar et al (2018)55 treated 40 bilateral grade II furcation defects with 1% 
Alendronate gel in combination with Platelet Rich Fibrin (Platelet Rich Fibrin+ 
Alendronate) and Platelet Rich Fibrin alone and at baseline, 3 and 6 months clinical 
and radiographical parameters were measured, in PRF with 1% Alendronate gel 
treated defects exhibited better outcomes suggestive of enhanced periodontal 
regeneration. 
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A comparative study of histological features of platelet rich fibrin and titanium 
prepared platelet rich fibrin in healthy, gingivitis and generalized chronic and 
aggressive periodontitis patients. This study was assessed and accepted by 
institutional ethics committee. The entire study and related agendas were explained to 
the patients and written informed consent was obtained from all the patients before 
the commencement of the study. A total of 60 patients were enlisted from the 
Department of Periodontics of Vivekanandha Dental College for Women, Tamil 
Nadu, depending on the following criteria. 
INCLUSION CRITERIA 
 Systemically healthy patients. 
 Age 20-60years. 
 Normal platelet count of 150,000–450,000 per microliter 
 Varying degree of periodontal health status (gingivitis and periodontitis). 
EXCLUSION CRITERIA 
 Tobacco Smoking or chewing habits. 
 Platelet & coagulation disorder. 
 Systemic diseases/conditions & medications affecting blood. 
 H/O antibiotics use or periodontal therapy within past 6 months. 
 Pregnancy or lactating women. 
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CRITERIA FOR GROUPING 
GROUP A: HEALTHY – Probing Depth 2-3 mm, No Clinical Attachment Loss, 
Gingival index = 0. 
GROUP B: GINGIVITIS – Probing depth 2-3 mm, No Clinical Attachment Loss, 
Gingival Index ≥ 1, positive Gingival Bleeding Index, Plaque Index. 
GROUP C: GENERALISED CHRONIC PERIODONTITIS- Pocket depth ≥ 4mm 
and Clinical Attachment Loss involving more than 30% of the sites. 
GROUP D: GENERALISED AGGRESSIVE PERIODONTITIS - Pocket depth ≥ 
4mm, interproximal attachment Loss  at least  three permanent teeth other than first 
molars and incisors. 
CLINICAL PARAMETERS  
The following variables were measured at baseline  
1. Plaque index  
2. Gingival index  
3. Gingival bleeding index  
4. Number of sites with probing depth ≥ 4mm  
PLAQUE INDEX (PI): (Turskey et al modification of Quigley Hein index, 
1970)56 
With the PI, mesial, distal, and mid surfaces of facial and lingual aspects were scored. 
Scoring was as follows:  
0= No plaque/debris  
1= Separate flecks of plaque at the cervical margin of the tooth 56 
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2 = A thin continuous band of plaque (up to 1 mm) at the cervical margin of the 
tooth.56 
3= A band of plaque wider than 1 mm but covering less than one third of the crown of 
the tooth.56 
4= Plaque covering at least one third but less than two thirds of the crown of the 
tooth.56 
5= Plaque covering two thirds or more of the crown of the tooth.56 
GINGIVAL INDEX (GI): (Loe and Silness 1964)57 
The Gingival Index records qualitative changes in the gingiva. The marginal and 
interproximal gingival scored separately. The criteria are:  
0= Normal gingiva;  
1= Mild inflammation – slight change in color and slight edema but no bleeding on 
probing57 
2= Moderate inflammation – redness, edema and glazing, bleeding on probing57 
3= Severe inflammation – marked redness and edema, ulceration with tendency to 
spontaneous bleeding.57 
The scores of the four areas of the tooth can be summed and divided by four to give 
the GI for the tooth57. A score from  
0.1-1.0 = Mild inflammation;  
1.1-2.0 = Moderate inflammation  
2.1-3.0 = Signifies severe inflammation.57 
GINGIVAL BLEEDING INDEX (GBI): (Ainamo and Bay, 1975)58 
Gingival bleeding index was based on recordings from all four tooth surfaces of all 
teeth. Percentage of affected sites was calculated by gingival bleeding index. It was 
recorded after 10 seconds of probing as - Bleeding present (+), Bleeding absent (–) 58 
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METHOD 
A blood sample of each volunteer was obtained from the antecubital vein of 
the subject’s right or left arm, (a total of 10 ml blood, was collected from patients with 
10 ml injectors). 5ml blood was transferred to disposable vacutainer, centrifuged for 
2800 for 12 min59and 5 ml in grade IV titanium tube at 3000 for 10 min60 in REMI 
centrifuge machine. Figure-3 
The PRF and T-PRF clots were removed from the respective tubes using sterile 
tweezers after centrifugation, RBC base layer were separated using scissors, and 
placed on sterile gauze. Both clots were left over 20 minutes on sterile gauze to 
release their serum. This PRF and T-PRF clots were used for the light microscopy 
analysis. 
Histological Procedures for Light Microscopy 
 Step 1: Fixing – Both the PRF and T-PRF clots were transferred into a 
perforated stainless steel cassette and identification of patient was written and 
was placed in 10% formalin-containing container. The PRF and T-PRF clots 
were then fixed for 24 hrs to prevent cell death and to preserve the biological 
tissues. 
 Step 2: Tissue processing – After 24 hrs of fixation, the cassette-containing 
clots were subjected to dehydration, clearing, and infiltration of wax into the 
clots as they passed through various processing solutions such as 10% 
formalin, 60%, 70%, 80%, 90%, and 100% isopropanol alcohol, xylene (two 
changes), and paraffin wax in an orderly manner. This process was continued 
in an automated tissue processor which enabled the removal the water from 
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tissue for 16 h and replaced in a medium that after solidification allow thin 
sections to be cut. Figure-7,8 
 Step 3: Embedding – Paraffin was used for tissue embedding. Figure-9 
 Step 4: Tissue sectioning – the PRF and TPRF clots were sliced using 
microtome about 4 μm thickness of tissue. Figure- 10,11 
 Step 5: Dewaxing – The deparaffinization of the slides was done by heating it 
for about 55°C, to eliminate wax enabling the tissues to be stained followed by 
dropping into xylene. Figure-12,13 
 Step 6: Tissue staining – Hematoxylin and eosin stain sections were used for 
staining. Figure-14  
 Step 7: Slide numbering – The slides were numbered based on the order for 
record 
 Step 8: Histological slide analysis – Following the preparation of stained 
section of PRF and T-PRF clot from Group A (healthy patients), Group B 
(gingivitis patients), and Group C ( generalized chronic periodontitis patients); 
Group D (generalized aggressive periodontitis patients), the slides were 
assessed with compound microscope at ×20 and ×40 magnifications to 
evaluate: Figure-15-22 
1. Presence of dense fibrin network 
2. Presence of loose fibrin network 
3. Enmeshment pattern of platelets and WBC cells within the dense and loose 
type of fibrin network. 
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                                                  PROFORMA 
 
Name:                                                           Date:     
 
O.P.No:                                                        Age/Sex: 
 
Address:                                                       Occupation:  
 
HISTORY 
 
 
Chief Complaint: 
 
 
 
Past Medical History: 
 
 
 
Past Dental History: 
 
 
 
Personal History: 
 
 
 
RADIOGRAPHIC FINDINGS: 
 
 
 
 
 
INTRAORAL EXAMINATION     
 
 
 
 
PLATELET COUNT:                                           
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 INDICES 
  
MODIFIED QUIGLEY HEIN PLAQUE INDEX :(Turesky et al 1970) 
 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
 
Score:                                                     Interpretation: 
 
 
GINGIVAL INDEX : (Loe&Silness 1963) 
 
      
16 12 24 36 32 44 
      
 
Score:                                                     Interpretation: 
 
 
GINGIVAL BLEEDING INDEX (Ainamo&Bay 1975) 
              
17 16 15 14 13 12 11 21 22 23 24 25 26 27 
              
 
              
47 46 45 44 43 42 41 31 32 33 34 35 36 37 
              
 
No of sites:                                            Percentage of sites: 
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PROBING DEPTH AND CLINICAL ATTACHMENT LEVEL: 
CAL                 CAL 
PD                 PD 
 18 17 16 15 14 13 12 11 21 22 23 24 25 26 27 28  
 48 47 46 45 44 43 42 41 31 32 33 34 35 36 37 38  
PD                 PD 
CAL                 CAL 
 
 
DIAGNOSIS PLATELET RICH 
FIBRIN 
TITANIUM PREPARED  
PLATELET RICH 
FIBRIN 
 
HEALTHY 
  
 
GINGIVITIS 
  
 
GENERALISED CHRONIC 
PERIODONTITIS 
  
GENERALISED 
AGGRESSIVE 
PERIODONTITIS 
  
 
HISTOLOGICAL INTERPRETATION 
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INFORMED CONSENT FORM 
 
Patient Name:                                               Age/Sex: 
Address: 
 
I have been explained the nature and purpose of the study in which I have 
been asked to participate. I understand that I am free to withdraw my consent and 
discontinue at any time without prejudice to me or effect on my treatment. I have 
been given the opportunity to question about the study and other procedures. I have 
also given consent for photographs to be taken at the beginning, during and end of the 
study. I agree to participate in the study. 
 
I hereby given the consent to be included in “EVALUATION OF FIBRIN 
NETWORK PATTERN CHANGES OF PLATELET RICH FIBRIN AND 
TITANIUM PREPARED PLATELET RICH FIBRIN OF INDIVIDUALS WITH 
AND WITHOUT PERIODONTITIS – A CELL BLOCK CYTOLOGY 
 
Place:                                                             
Date:                                                            
 
                                                            Signature of patient 
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தகவ ஒ~©ைம பவ 
 
ேநாயாள ெபயƫ:                             Mz;/ngz;. 
taJ:                                            Kfthp                                                                      
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ARMAMENTARIUM 
 
MATERIALS AND INSTRUMENTS USED: 
 
Gloves  
Mouth mask  
Patient apron  
Chair apron  
Head cap  
Sterile cotton rolls  
Gauze  
Kidney tray  
Syringe  
Mouth mirror  
Straight probe  
Explorer  
William’s probe  
Tweezers 
 Tourniquet 
 Scissors 
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MATERIALS AND INSTRUMENTS FOR PREPARATION OF 
PRF AND T-PRF: 
 Sterile grade IV titanium tubes29 
 Sterile vacutainer. 
 10 ml syringe. 
 REMI centrifuge machine for centrifugation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Photographs 
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Armamentarium 
 
Figure-1 
 
Blood Collection                               Centrifugation Machine 
 
       
              Figure-2                                                                           Figure-3 
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Vacutainers                                           Titanium Tubes 
        
                                  Figure -4                                                        Figure-5 
 
Platelet Rich Fibrin And Titanium Platelet Rich Fibrin Clot Obtained 
 
 
 
 
 
 
 
                            
                                  
                                                            Figure-6 
                                                     Tissue Processing 
                   
                                    
 
 
 
 
 
 
 
                                
                       Figure- 7                                                     Figure-8                                                                       
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Embedding 
 Figure-9 
 
Tissue Sectioning Of  PRF And T PRF Clot 
      
 
Figure-10                                                        Figure-11 
 
Dewaxing Done Tissue Floating Bath 
 
Figure-12 
 
Materials and Methods 
 
35 
 
After Dewaxing 
 
 
Figure-13 
 
 
 
PRF And T PRF Clot Slides Prepared 
 
 
Figure-14 
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Microscopic view of PRFand TPRF clot under manification 
 
Healthy PRF and T PRF Clot 
    
Figure-15 Figure-16 
 
Gingivitis PRF and T PRF Clot 
    
Figure-17                                              Figure-18 
 
 Generalized Chronic Periodontitis PRF and T PRF Clot
     
Figure-19                                                         Figure-20 
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Generalised aggressive periodontitis PRF and TPRF 
 
       
 
Figure-21                                                         Figure-22 
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The results obtained in this study were statistically analyzed and the normality 
tests Kolmogorov-Smirnov and Shapiro-Wilks tests results reveal that the variable 
(Age) follows Normal distribution. Therefore, to analyses the data parametric 
methods are applied. To compare mean age in years between the groups independent 
samples t-test is applied. To compare the mean age between groups one way ANOVA 
is applied followed by Tukey’s HSD post hoc tests for multiple pairwise comparisons. 
To compare proportions between study and control groups Chi-Square test is applied, 
if any expected cell frequency is less than five then Fisher’s exact test is used. To 
analyze the data SPSS (IBM SPSS Statistics for Windows, Version 23.0, Armonk, 
NY: IBM Corp. Released 2015) is used and 5 % (α = 0.05) fixed as significance level. 
The histological section of PRF and T-PRF of all participants showed 
outermost layer of RBC with dense fibrin network layer with more platelets and 
WBCs entrapment and inner layers with loose fibrin network with entrapment of 
platelet and WBC. 
The presence of dense and loose fibrin network were analyzed and its 
percentage difference was investigated and the difference between the PRF and T-
PRF fibrin matrix compared. The differences and percentage variation were compared 
in periodontal disease patients. Healthy, gingivitis and chronic periodontitis and 
aggressive periodontitis patients were excluded because of less sample size than other 
groups. 
Platelet rich fibrin and titanium Platelet rich fibrin in healthy 
individuals 
Both loose fibrin network and dense network were found and entrapment of 
platelet and WBC cells in both layers. The percentage of loose fibrin network was 
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more as compared to dense fibrin network, and entrapment of platelets and WBC cells 
was aggregated within the dense fibrin network whereas fewer cells were diffusely 
arranged in loose fibrin network. There was no well-defined demarcation between the 
loose fibrin network and dense fibrin network 
The mean age groups of healthy patients were 27.85 years with a standard 
deviation of 4.24.Table -1. The percentage of loose fibrin network was about 85 % 
with mean age of 27.18 and dense fibrin network was about 15% in mean age of 
31.67 with less percentage of platelet and WBC entrapment. Table -4 
The T-PRF clot showed highly organized dense fibrin network with 100% 
with mean age of 27.85 with standard deviation of 4.24 as in Table -5 as compared to 
healthy PRF clot with less percentage of loose fibrin network. There was a well-
defined demarcation between loose fibrin network and fibrin network pattern in this 
group. 
Platelet-rich fibrin and titanium platelet-rich fibrin clot in gingivitis 
patients 
The histological section of both PRF and T-PRF clot showed the following.  
Both layers were found. The PRF clot occupied higher percentage of loose fibrin clot 
with about total of 86% with mean age difference of 30.53 and dense fibrin network 
about 14% in the gingivitis group with mean age of 30.33 with standard deviation of 
8.59 which with less amount of cellular component of platelet and WBC but 
compared to healthy individual more entrapment were found. Table -1 
In T-PRF clot, loose fibrin network was less, dense fibrin network was present 
in an increased quantity with mean age of 30.50 and standard deviation about 8.59 
which showed an increased amount of cellular components were diffusely arranged 
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all through the clot. The demarcation between loose and dense fibrin were well 
defined. 
Platelet-rich fibrin and titanium platelet-rich fibrin clot in  
periodontitis patients 
With chronic periodontitis patients mean age was 39.75 with standard 
deviation of 8.22. In PRF clot, both dense and fibrin network was present compared to 
the dense fibrin mesh, the loose fibrin mesh was dominant with the percentage of 87% 
and 13 % of dense fibrin network. The loose fibrin network the mean age were 39.35 
and dense fibrin network with 42.00.The WBC and platelet aggregates were seen 
higher in the dense fibrin network and the rest part of the clot; the entrapment of cells 
was scattered. 
In the T-PRF clot, the mean age was 39.75 with standard deviation of 8.22 the 
presence of both dense and light fibrin networks was homogeneously present. 
However, as compared to PRF clot of the same chronic periodontitis  individual, T-
PRF clot showed thick dense fibrin layer more amount of entrapment of platelets and 
WBC in the dense fibrin network as compared to loose network and the presence of a 
fragile fibrin border which was completely absent in PRF clot. 
In 10 Generalized Aggressive Periodontitis patients the fibrin network patterns 
of PRF have both loose and dense fibrin network were seen with loose fibrin were 
more and increased aggregation of platelet and WBCs were seen and in T-PRF group 
showed thicker dense layer and increased cells compared to PRF group which similar 
to chronic periodontitis patients. Figure -21, 22. 
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TABLE-1 
 
ONE-WAY ANOVA TO COMPARE MEAN AGE BETWEEN 
GROUPS 
 
 
Group N Mean Age (years) Std. Dev 
95% CI for Mean 
F-value p-value 
LB UB 
Healthy 20 27.85 4.246 25.86 29.84 
14.679 <0.001 Gingivitis 20 30.50 8.593 26.48 34.52 
Periodontitis 20 39.75 8.226 35.90 43.60 
Total 60 32.70 8.823 30.42 34.98   
 
 
 
 
 
TABLE-2 
 
TUKEY HSD POST HOC TESTS FOR MULTIPLE 
COMPARISONS 
 
 
Group Mean Difference p-value 
Healthy Gingivitis -2.65 0.488 
Periodontitis -11.90 <0.001 
Gingivitis Periodontitis -9.25 0.001 
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TABLE- 3 
CHI-SQUARE TEST TO COMPARE PROPORTIONS BETWEEN 
GROUPS 
 
 
Group 
PRF 
Loose Dense Total 
% % % 
Healthy (20) 85.0% 15.0% 100.0% 
Gingivitis(20) 85.0% 15.0% 100.0% 
Periodontitis(20) 83.0% 17.0% 100.0% 
Total(100) 85.0% 15.0% 100.0% 
 
 
Chi-Square Test Value p-value 
Fisher's Exact Test 0.151 1.000 
 
 
 
 
 
Group 
TPRF 
Dense Thick dense Total 
N % N % N % 
Healthy 20 100.0% 0 0.0% 20 100.0% 
Gingivitis 20 100.0% 0 0.0% 20 100.0% 
Periodontitis 0 0.0% 20 100.0% 20 100.0% 
Total 40 66.7% 20 33.3% 60 100.0% 
 
 
Chi-Square Test Value p-value 
Pearson Chi-Square 60.000 <0.001 
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TABLE-4 
INDEPENDENT SAMPLE T-TEST TO COMPARE MEAN AGE 
BETWEEN LOOSE AND DENSE PRF (OVERALL) 
PRF N Mean Age (years) Std. Dev t-value p-value 
Loose 51 32.35 8.944 0.722 0.473 Dense 9 34.67 8.307 
 
 
 
 
 
 
INDEPENDENT SAMPLE T-TEST TO COMPARE MEAN AGE 
BETWEEN LOOSE AND DENSE PRF (GROUP WISE) 
Group PRF N Mean Age (years) Std. Dev t-value p-value 
Healthy Loose 17 27.18 3.795 1.783 0.091 Dense 3 31.67 5.508 
Gingivitis Loose 17 30.53 9.063 0.035 0.972 Dense 3 30.33 6.658 
Periodontitis Loose 17 39.35 8.329 0.504 0.621 Dense 3 42.00 8.888 
 
 
 
 
ONE-WAY ANOVA TO COMPARE MEAN AGE BETWEEN 
GROUPS AMONG LOOSE PRF 
 
Group N Mean Age (years) Std. Dev 
95% CI for Mean F-value p-value LB UB 
Healthy 17 27.18 3.795 25.23 29.13 
12.161 <0.001 Gingivitis 17 30.53 9.063 25.87 35.19 
Periodontitis 17 39.35 8.329 35.07 43.64 
Total 51 32.35 8.944 29.84 34.87   
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TUKEY HSD POST HOC TESTS FOR MULTIPLE 
COMPARISONS 
 
Group Mean Difference p-value 
Healthy Gingivitis -3.353 0.394 
Periodontitis -12.176 <0.001 
Gingivitis Periodontitis -8.824 0.003 
 
 
 
 
 
 
ONE-WAY ANOVA TO COMPARE MEAN AGE BETWEEN 
GROUPS AMONG DENSE PRF 
 
Group N Mean Age (years) Std. Dev 
95% CI for Mean F-value p-value LB UB 
Healthy 3 31.67 5.508 17.99 45.35 
2.388 0.173 Gingivitis 3 30.33 6.658 13.79 46.87 
Periodontitis 3 42.00 8.888 19.92 64.08 
Total 9 34.67 8.307 28.28 41.05   
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TABLE-5 
INDEPENDENT SAMPLE T-TEST TO COMPARE MEAN AGE 
BETWEEN DENSE AND THICK DENSE T-PRF (OVERALL) 
 
PRF N Mean Age (years) Std. Dev t-value p-value 
Loose 40 29.18 6.823 5.281 <0.001 Dense 20 39.75 8.226 
 
 
 
 
INDEPENDENT SAMPLE T-TEST TO COMPARE MEAN AGE 
BETWEEN DENSE AND THICK DENSE T-PRF (GROUP WISE) 
 
Group TPRF N Mean Age (years) Std. Dev p-value* 
Healthy Dense 20 27.85 4.246 - Thick dense 0 . . 
Gingivitis Dense 20 30.50 8.593 - Thick dense 0 . . 
Periodontitis Dense 0 . . - Thick dense 20 39.75 8.226 
   * p-value cannot be computed because at least one of the groups is empty. 
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ONE-WAY ANOVA TO COMPARE MEAN AGE BETWEEN GROUPS 
AMONG DENSE T-PRF 
 
Group N Mean Age (years) Std. Dev 
95% CI for Mean F-value p-value LB UB 
Healthy 20 27.85 4.246 25.86 29.84 1.529 0.224 Gingivitis 20 30.50 8.593 26.48 34.52 
Total 40 29.18 6.823 26.99 31.36   
 
 
 
 
Group TPRF 
PRF 
Loose Dense Total 
N % N % N % 
Healthy Dense 17 85.0% 3 15.0% 20 100.0% 
Thick dense 0 0.0% 0 0.0% 0 0.0% 
Total 17 85.0% 3 15.0% 20 100.0% 
Gingivitis Dense 17 85.0% 3 15.0% 20 100.0% 
Thick dense 0 0.0% 0 0.0% 0 0.0% 
Total 17 85.0% 3 15.0% 20 100.0% 
Periodontitis Dense 0 0.0% 0 0.0% 0 0.0% 
Thick dense 17 85.0% 3 15.0% 20 100.0% 
Total 17 85.0% 3 15.0% 20 100.0% 
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In this study, fibrin network patterns of platelet rich fibrin and titanium 
prepared platelet rich fibrin of patients with gingivitis, chronic periodontitis, and 
aggressive periodontitis were compared with healthy patients through histological 
analysis. As per our knowledge of the literature, this study was the first conducted on 
the variation of fibrin network pattern in periodontal disease conditions. The 
importance of understanding these variations in periodontal disease patients in the 
platelet concentrates could be because it contains higher concentrations of growth 
factors which could play an important role in the regeneration of the lost tissues. 
Platelet glycoprotein binds to fibrinogen which reliant the platelet thrombus on 
formation and helps in cross-linking of the platelets61, and the fibrin collagen 
component triggers this platelet thrombus formation.  
Platelet concentrates were used initially for the treatment of severe 
thrombopenia which was characterized by hemorrhage. They were also used for 
wound healing which lead to introduction of fibrin glues contains concentrated 
fibrinogen 40 years ago. These adhesives were procured commercially or obtained 
from the patients because of the cost of production and risk in transmission of 
diseases.  
 A newer platelet concentrate was identified and it was called platelet rich 
plasma (PRP) in the early 1990s. It was obtained by means of plasmapheresis and 
PRP sequestration.  It contains 95% of platelets, 4% of RBCs and 1 % of WBCs. This 
platelet secretes growth factors which initiates wound healing process and the protein 
present in it helps in cell adhesion and act as matrix for bone, connective tissue and 
epithelial migration. Advantages of PRP are safe, cost effective, auotologous product, 
no risk in disease transmission or immunogenic reactions and remains stable and 
sterile in the anticougulated state for 8 hours. Hence it can be used for longer 
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surgeries. Disadvantages of PRP were difficult to handle and requires secure 
implantation in specific site. Saluja et al 2011 showed that PRP has limited potential 
to induce bone regeneration because growth factors are released quickly before the 
surrounding cell outgrowth. 
To overcome the limitations of PRP, Choukroun et al 2001developed platelet 
rich fibrin PRF widely used to induce soft and hard tissue healing. The PRF 
production protocol attempts to accumulate cytokines and platelets in a fibrin clot. It 
can be used as a clot or as a membrane after compression. Toffler et al 2009, Dohan 
et al 2010. There are two types of PRF- Leucocyte-poor or pure platelet rich fibrin (P-
PRF), Leucocyte-rich platelet rich fibrin (L-PRF) or Choukroun’s PRF. 
Leucocyte-poor or pure platelet rich fibrin (P-PRF) prepared by collecting 
blood is in a tube containing anticoagulant and centrifuged for 6 minutes. The 
obtained buffy coat and PPP are transferred to second tube containing calcium 
chloride which helps in triggering the clotting process and centrifuged for 15 minutes. 
The fibrin matrix is denser and more stable than PRPs. 
Choukroun’s PRF was prepared by centrifuging the collected blood without 
anticoagulant. The absence of anticoagulant allows activation of majority of platelets 
and increased fibrinogen in the upper part of the tube, until the thrombin transforms to 
fibrin network. Middle of the tube contains fibrin clot with platelets.  It does not 
dissolve quickly after application unlike the PRPs. 
Advantages of PRF are ease of preparation, lack of biochemical modification, 
increased incorporation of cytokines in the fibrin meshes (intrinsic cytokines), and 
minimal expense. Quick handling to get a clinically usable PRF clot was the only 
disadvantage.  
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During gelling of PRF, the fibrin fibrillae arranged in two different 
biochemical architectures bilateral junctions or condensed tetramolecular junctions 
and connected trimolecular or equilateral junctions. The strong thrombin 
concentrations in the bilateral junctions allows thickening of fibrin polymers leading 
to rigid network, unfavorable to cytokines enmeshment and migration of cells. Weak 
thrombin in equilateral junctions leads to a fine and flexible fibrin network favorable 
to cell migration and cytokines. 
Platelet rich fibrin has to be considered as a fibrin biomaterial and a favorable 
loose and dense fibrin matrix for migration of endothelial cells and fibroblasts which 
helps in rapid angiogenesis and remodeling of tissues. The dense fibrin matrix in clots 
have more entrapment of inflammatory cells and platelets which helps in enhanced 
wound healing and or regeneration of periodontal tissue. Therefore, these PRF clots 
can be used for all types of superficial cutaneous and mucous healing. 
The glass evacuated collection tubes with silica activators are used during 
preparation of PRF.  These silica particles found in sediment with red blood cells, 
fibrin, and buffy coat and might reach the patient when product used for the treatment. 
In order to overcome this, Titanium prepared platelet rich fibrin was identified, where 
grade IV titanium tubes are used for preparation at 3500rpm for 15 minutes. Platelet 
activation was found to be similar to glass tubes and showed increased 
biocompatibility 
New products titanium prepared platelet-rich fibrin (T-PRF), advanced 
platelet-rich fibrin (APRF), and concentrated growth factors (CGF)have been 
developed in recent years to improve PRF and to get rid of the limitations. 
Recently, Ghanaati et al.62developed a new fibrin structure (A-PRF) with a 
decrease in centrifugation speed and an increase in centrifugation time. The 
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centrifugal force also influences the specific cell types scattered differentially in the 
clot. 
Periodontitis is a chronic infectious disease, and this inflammation of the 
supporting periodontal tissues results in pocket formation and epithelial ulceration. 
This lead to transient bacteremias2, 3 which in turn lead to the production of pro 
inflammatory mediators like interleukin (IL-1β), IL-6, tumor necrosis factor TNF-α, C 
- reactive protein and resulting in platelet binding to leucocytes and endothelial cells. 
These make platelet important factor in both thrombotic and inflammatory 
reactions in the vasculature.63this activation of platelet is responsible for the 
development of atherosclerosis, atherothrombosis and subsequent coronary vascular 
and cerebrovascular disease. 
Dimitris Papapanagiotou et al64investigated the soluble P-selectin and sCD40 
ligand and surface-exposed P-selectin and the ligand-binding conformation of the 
glycoprotein IIb–IIIa complex (binding of PAC-1 antibody) in the plasma, it was used 
as marker for platelet activation in periodontitits patients and healthy patients. He 
found activation of platelet was more pronounced in patients with more severe 
periodontal disease. 
Mario Romandini et al 201865 found that severe periodontitis displayed more 
platelets for μl of blood and has shown to be highlighted in older patients, females, 
non- smoker and with normal HDL blood levels.  
In this study, generalized aggressive periodontitis patients the PRF clots with 
predominant dense fibrin layer and TPRF clots showed both loose and dense fibrin 
matrix with increased platelets and WBCs entrapment when compared to healthy and 
gingivitis patients this may be because of the  oral bacteria Aggregatibacter 
actinomycetemcomitans (Aa) causing periodontitis responsible for the increase 
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platelet and increased formation of platelet –leukocyte complexes with elevated 
capacity of for bacterial clearance.66 
The platelets are hyper-reactive in patients with periodontitis and forms more 
platelet- leucocyte complexes compared to healthy patients. In response to P.gingvalis 
lead to the formation of platelet -leukocyte complexes and reduced at recall after 
periodontal therapy.67 
Chronic periodontitis patients demonstrated a significantly higher WBC count 
7.22±1.42× 109 cells/L and also platelet count (290.73 ± 56.56 · 109 cells/L) 
systemically higher than the healthy patients.68Hence the influence of systemic and 
periodontal diseases was a necessary to assess the quality of fibrin network pattern of 
platelet rich fibrin and titanium prepared platelet rich fibrin. 
The variation in fibrin network pattern changes of PRF clot at various age 
groups was evaluated, wherein older age group period, loose fibrin network and 
scanty entrapment of WBC and platelets were found which correlates with this study8. 
On histological sectioning, larger fibrin network area was observed in TPRF fibrin 
than leukocyte- and platelet-rich fibrin network and also, fibrin seemed thicker in the 
TPRF samples. Thus, platelet activation by titanium tubes has shown higher 
characteristics.29 
Dohan et al. observed the cytokines and fine flexible fibrin network and 
stabilization of the wound by using platelet concentrate in regeneration process.12 
Laurens et al. stated that the fibrin structure, such as the thickness of the fibers, the 
number of branch points, the porosity, and the permeability of platelet rich fibrin 
greatly influences the wound healing. It also depends on platelet concentrates and 
their functions.64 
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 We excluded smoking patients and platelet & coagulation disorder patients, 
systemic diseases because of various factors affect the fibrin matrix formation, and 
the entrapment of WBC and leukocytes changes due to change in vascularity which 
may be due to genetic factors and acquired factors (abnormal concentration of factor 
XIII and thrombin in plasma, hypertension, blood flow, platelet activation, oxidative 
stress, hyperglycemia, hyperhomocysteinemia, medications, and cigarette smoking).65 
Titanium is a non-corrosive material which is compatible to cell and tissue 
(cytocompatibility) and blood (hemocompatibility). The medical grade titanium 
showed variation in the platelet and leucocyte, reduction in platelet number and 
surface variations has no thrombogenic variations69. 
Hence the present study examined the histological assessment of fibrin 
network pattern and its interaction with platelets and WBC in healthy, gingivitis and 
periodontitis.The healthy patients with 27.85 years with a standard deviation of 
4.24.Table -1. The percentage of loose fibrin network was about 85 % with mean age 
of 27.18 and dense fibrin network was about 15% in mean age of 31.67with less 
percentages of platelet and WBC entrapment. Table -4.The TPRF clot showed highly 
organized dense fibrin network with 100% with mean age of 27.85 with standard 
deviation of 4.24 as in Table -5 which was correlated with the histological section 
evaluation done by Tunali et al 2014. 
In Gingivitis patients, it also showed both loose and dense fibrin network with 
the PRF clot occupied higher percentage of loose fibrin clot with about total of 86% 
and decreased platelet aggregation. But TPRF showed denser matrix and increased 
platelet aggregation than PRF gingivitis group as in figure16, 18, and 20. 
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In Generalized Chronic Periodontitis patients, The loose fibrin mesh was 
dominant with the percentage of 87% and 13 % of dense fibrin network in PRF group 
and TPRF clot showed thick dense fibrin layer maximum amount of entrapment of 
platelets both PRF and TPRF clots showed both loose fibrin network and dense fibrin 
network with more platelet aggregation in dense fibrin network and thick fibrin border 
was also appreciated in periodontitis patients when compared to healthy patients as in 
Table -5 and chart-3. 
In Generalized Aggressive Periodontitis patients showed predominant loose 
fibrin network in the PRF group and in TPRF group showed more of dense layer and 
increased inflammatory cells and platelets.  In this study all the patients of TPRF 
group healthy, gingivitis and chronic and aggressive periodontitis patients have 
showed well organized fibrin mesh structure with continuous integrity with 100% of 
dense fibrin matrix and100% of thick dense pattern in periodontitis patients as in chart 
-3. The RBC and leucocytes are easily detectable when compared to PRF groups. 
Here one the factor platelet activation could be the cause for the variation of PRF and 
TPRF in fibrin matrix and platelet aggregation in this study. In periodontal disease 
low grade systemic inflammation which triggers the platelet formation more. 
Anirban Chatterjee et al 201748evaluated fibrin clot pattern in hypertensive 
and smoker participant varied as compared to healthy participants in PRF and TPRF 
clot, but a better organization of meshwork and increased entrapment of cells were 
appreciated in TPRF clot. Since both systemic condition causes changes in the 
network pattern of platelet rich fibrin and titanium prepared platelet rich fibrin. Based 
on this article this study was performed to see variation of these clot in gingivitis and 
periodontitis patients. 
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This study accentuated the influence of diseased oral condition like gingivitis 
and periodontitis which could recast the fibrin clot formation, fibrin network contrast 
and its interaction of cellular component. From this study we interpret that using 
titanium to prepare PRF enhances its quality of the fibrin network which was found 
have better regenerative capacity52.To certain variations and limitations of this study, 
variation in age groups, platelet count distribution evaluation of fibrin clot of 
individual having gingivitis and periodontitis patients compared with healthy patients 
could have yielded a better validation. Histologically, correct appreciation of the 
changes in the individual fibrin thickness, morphology and, hindrance in recognizing 
and isolating out the platelets and WBC cells by hematoxylin staining, and precise 
counting of the platelets entrapped within the fibrin meshwork were difficult. 
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This study defined and evaluated the fibrin network pattern changes of Platelet 
rich fibrin and Titanium prepared platelet rich fibrin clot by histological method in 
patients with periodontal diseases which varied compared to healthy individuals. 
Total of 60 patients were divided into 4 groups Healthy, Gingivitis, Generalized 
Chronic Periodontitis and 10 Generalized Aggressive Periodontitis patients. Baseline 
clinical parameters were assessed to confirm the diagnosis like probing depth, clinical 
attachment loss, plaque index, gingival index, bleeding index. In each patient, 10 ml 
blood was drawn and divided for centrifugation to obtain PRF and T-PRF clot and the 
specimens were obtained by fixing, tissue processing, embedding, tissue sectioning, 
dewaxing, tissue staining and finally slide preparation. Then histological analysis was 
done by compound microscope at 20X and 40X magnification.  
On analysis, the healthy and Gingivitis patients showed no significance 
variations in fibrin matrix formation in the PRF group, but in Generalized Chronic 
Periodontitis and Generalized Aggressive Periodontitis patients more cellular 
entrapment, matrix formation was found and in T-PRF on the whole it showed thick 
dense fibrin matrix and well organized fibrin border and increased entrapment of 
cellular components and this was more exaggerated in generalized chronic and 
aggressive periodontitis patients. With limitations in this study, more research on 
clinical parameters such as resorption time, clinical outcome and other systemic 
factors that influences the fibrin network are required. 
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